Diverse RNA expression patterns of T cell priming markers in various solid tumors and their clinical implication
T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
Complex markers of survival from pembrolizumab: The potential predictive role of tumor mutational burden (TMB) and KRAS
